UCI Receives $6M Grant to Study Jaw Joint Implant
UCI said it received a $6 million grant from the California Institute for Regenerative Medicine to perform preclinical trial studies on jaw joint implant Hyaleon. Hyaleon, the main product of UCI-based startup Cartilage Inc., aims to treat adults living with a temporomandibular joint (TMJ) disorder. According to officials, about one in four adults suffer from a TMJ pathology, and up to 70% of cases involve displacement of the TMJ disk.